News

Personalis, Inc. has joined with Duke University and Olink Proteomics AB to form a research collaboration to study the effects of immunotherapy on advanced gastroesophageal cancer.…
Read More...

miRecule, Inc., an innovator of next-generation RNA therapeutics, announced a strategic collaboration and exclusive license agreement with Sanofi to develop and commercialize a…
Read More...

Japanese pharmaceutical company Shionogi & Co., Ltd. and the Medicines Patent Pool (MPP), a United Nations-backed public health organisation, reflecting a shared commitment to…
Read More...

Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today the opening of a new research and…
Read More...

Pfizer Inc. announced the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC ODT (rimegepant), an innovative migraine therapy approved…
Read More...

Biogen Inc. and Denali Therapeutics Inc. announced that dosing has commenced in the global Phase 3 LIGHTHOUSE study to evaluate the efficacy and safety profile of BIIB122 (DNL151), as…
Read More...

AmplifyBio, a contract research organization (CRO) focused on accelerating innovation across pharmaceutical modalities; announced the acquisition of select assets from PACT Pharma,…
Read More...

Alexion, AstraZeneca Rare Disease, announced that it has entered a definitive agreement to acquire Lexington, Mass.-based LogicBio Therapeutics, Inc., a pioneering genomic medicine…
Read More...

Vanda Pharmaceuticals Inc. (Vanda) and OliPass Corporation (OliPass) announced that they have entered into a research and development collaboration agreement to jointly develop a set of…
Read More...

InflaRx N.V. submitted a request for Emergency Use Authorization (EUA) following encouraging interactions with the US Food and Drug Administration (FDA) at a Type B meeting held this…
Read More...

Ventus Therapeutics, Inc., a biopharmaceutical company utilizing structural biology and a proprietary computational chemistry platform to identify and develop small molecule…
Read More...

Amylyx Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved RELYVRIO™ (sodium phenylbutyrate and taurursodiol) for the treatment of adults with…
Read More...

Myovant Sciences Ltd. confirmed that it has received a preliminary, non-binding proposal from Sumitovant Biopharma Ltd. and Sumitomo Pharma Co., Ltd. to acquire the remaining shares of…
Read More...

McKesson Corporation announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty…
Read More...

Simcere will receive a $15 million upfront payment and up to US$492 million in development and commercial milestone payments considering successful achievements in several…
Read More...

Moderna, Inc. is filing patent infringement lawsuits against Pfizer and BioNTech in the United States District Court for the District of Massachusetts and the Regional Court of…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adult patients with prurigo nodularis. With this approval, Dupixent becomes the first…
Read More...

Thermo Fisher Scientific Inc., the world leader in serving science, unveiled the Thermo Scientific DynaSpin Single-Use Centrifuge system at the BioProcess International annual…
Read More...

Verismo Therapeutics, a clinical-stage CAR-T company and Penn spinout, and pioneer of the novel KIR-CAR platform technology, announced that the U.S. Food and Drug Administration (FDA)…
Read More...

Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, launched following the closing…
Read More...